Volume | 18 202 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 0,72 | Bas Haut |
|||||
Minimum Bas | 0,69 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Phio Pharmaceuticals Corporation | PHIO | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,7184 | 0,69 | 0,72 | 0,7002 | 0,7263 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
237 | 18 202 | US$ 0,708247 | US$ 12 892 | - | 0,50 - 3,23 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
22:57:11 | 50 | US$ 0,70 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
3,21M | 4,59M | - | 0 | -10,83M | -2,36 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Phio Pharmaceuticals
Date | Heure | Source | Titre |
---|---|---|---|
28/5/2024 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
20/5/2024 | 23:03 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
20/5/2024 | 22:59 | Edgar (US Regulatory) | Form RW - Registration Withdrawal Request |
17/5/2024 | 22:45 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
17/5/2024 | 15:04 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
17/5/2024 | 15:00 | GlobeNewswire Inc. | Phio Pharmaceuticals Secures New Investor |
17/5/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
16/5/2024 | 14:00 | GlobeNewswire Inc. | Phio Pharmaceuticals Presents This Week at the Society for.. |
15/5/2024 | 19:00 | GlobeNewswire Inc. | Phio Pharmaceuticals Announces Completion of Dosing in First.. |
09/5/2024 | 23:25 | GlobeNewswire Inc. | Phio Pharmaceuticals Reports Q1 2024 Results and Provides.. |
09/5/2024 | 23:23 | Edgar (US Regulatory) | Form 8-K - Current report |
09/5/2024 | 23:20 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Forum Action Phio Pharmaceuticals
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Phio Pharmaceuticals Corporation
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,7129 | 0,74 | 0,68 | 0,7005455 | 32 591 | -0,0127 | -1,78% |
1 mois | 0,7527 | 0,78 | 0,68 | 0,7220612 | 39 612 | -0,0525 | -6,97% |
3 mois | 0,68 | 1,05 | 0,604849 | 0,7947669 | 214 531 | 0,0202 | 2,97% |
6 mois | 0,752 | 1,15 | 0,50 | 0,8208376 | 266 171 | -0,0518 | -6,89% |
1 an | 2,89 | 3,23 | 0,50 | 1,81 | 519 359 | -2,19 | -75,77% |
3 ans | 28,68 | 29,64 | 0,50 | 14,26 | 659 769 | -27,98 | -97,56% |
5 ans | 4,6068 | 130,20 | 0,50 | 19,16 | 722 931 | -3,91 | -84,80% |